Khan N, Alqarni S, Yousuf A, Shehzad I, Khan W, Gu W
Discov Oncol. 2025; 16(1):289.
PMID: 40063134
PMC: 11893934.
DOI: 10.1007/s12672-025-02012-5.
Ruberu T, Braun D, Parmigiani G, Biswas S
Stat Med. 2025; 44(3-4):e10323.
PMID: 39865362
PMC: 11881752.
DOI: 10.1002/sim.10323.
Henkel J, Laner A, Locher M, Wohlfrom T, Neitzel B, Becker K
Breast. 2025; 80:103887.
PMID: 39854808
PMC: 11804772.
DOI: 10.1016/j.breast.2025.103887.
Ruberu T, Braun D, Parmigiani G, Biswas S
Biometrics. 2024; 80(2).
PMID: 38819308
PMC: 11140851.
DOI: 10.1093/biomtc/ujae038.
Sousa N, Peleteiro B, Fougo J
J Cancer Res Clin Oncol. 2023; 150(1):1.
PMID: 38153534
DOI: 10.1007/s00432-023-05513-4.
Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease.
Zhang J, Dos Anjos C, Sevilimedu V, Crown A, Amoroso K, Pilewskie M
Ann Surg Oncol. 2023; 30(12):6990-6999.
PMID: 37661222
PMC: 11005956.
DOI: 10.1245/s10434-023-14141-8.
Triple-Negative Breast Cancer: Basic Biology and Immuno-Oncolytic Viruses.
Monaco M, Idris O, Essani K
Cancers (Basel). 2023; 15(8).
PMID: 37190321
PMC: 10137028.
DOI: 10.3390/cancers15082393.
Diagnostic yield and clinical relevance of expanded germline genetic testing for nearly 7000 suspected HBOC patients.
Henkel J, Laner A, Locher M, Wohlfrom T, Neitzel B, Becker K
Eur J Hum Genet. 2023; 31(8):925-930.
PMID: 37188824
PMC: 10400578.
DOI: 10.1038/s41431-023-01380-2.
The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies.
Czegle I, Huang C, Soria P, Purkiss D, Shields A, Wappler-Guzzetta E
Life (Basel). 2023; 13(4).
PMID: 37109525
PMC: 10145875.
DOI: 10.3390/life13040996.
Mutations in exon 11 (11.1 and 11.2) of the gene and risk factors for breast cancer in Burkina Faso.
Kiendrebeogo I, Zoure A, Zongo F, Ouattara A, Ouedraogo M, Amegnona J
J Public Health Afr. 2022; 13(1):1921.
PMID: 35720803
PMC: 9202467.
DOI: 10.4081/jphia.2022.1921.
ZFP281-BRCA2 prevents R-loop accumulation during DNA replication.
Wang Y, Ma B, Liu X, Gao G, Che Z, Fan M
Nat Commun. 2022; 13(1):3493.
PMID: 35715464
PMC: 9205938.
DOI: 10.1038/s41467-022-31211-9.
Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer.
Haneda E, Sato A, Suganuma N, Sebata Y, Okamoto S, Toda S
Int J Environ Res Public Health. 2022; 19(10).
PMID: 35627717
PMC: 9140389.
DOI: 10.3390/ijerph19106182.
Assessment of the Risk of Breast Cancer Development Applying NCI Tool among Iraqi Women.
Al Talebi Z, Ali S, Kareem Z, Al-Koofee D
Asian Pac J Cancer Prev. 2021; 22(10):3121-3126.
PMID: 34710987
PMC: 8858262.
DOI: 10.31557/APJCP.2021.22.10.3121.
Association between single-nucleotide polymorphisms in miRNA and breast cancer risk: an updated review.
Arancibia T, Morales-Pison S, Maldonado E, Jara L
Biol Res. 2021; 54(1):26.
PMID: 34454612
PMC: 8401249.
DOI: 10.1186/s40659-021-00349-z.
Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions.
Guglielmi C, Scarpitta R, Gambino G, Conti E, Belle F, Tancredi M
Int J Mol Sci. 2021; 22(14).
PMID: 34299313
PMC: 8305371.
DOI: 10.3390/ijms22147693.
Increased gene expression variability in BRCA1-associated and basal-like breast tumours.
Wiggins G, Black M, Dunbier A, Morley-Bunker A, Pearson J, Walker L
Breast Cancer Res Treat. 2021; 189(2):363-375.
PMID: 34287743
PMC: 8357684.
DOI: 10.1007/s10549-021-06328-y.
Molecular Perspective of Nanoparticle Mediated Therapeutic Targeting in Breast Cancer: An Odyssey of Endoplasmic Reticulum Unfolded Protein Response (UPR) and Beyond.
Rahman S, Kumar V, Kumar A, Abdullah T, Rather I, Jan A
Biomedicines. 2021; 9(6).
PMID: 34199484
PMC: 8229605.
DOI: 10.3390/biomedicines9060635.
Rare Coding Variants Associated with Breast Cancer.
Han M
Adv Exp Med Biol. 2021; 1187:435-453.
PMID: 33983593
DOI: 10.1007/978-981-32-9620-6_23.
Cancer Progress and Priorities: Breast Cancer.
Houghton S, Hankinson S
Cancer Epidemiol Biomarkers Prev. 2021; 30(5):822-844.
PMID: 33947744
PMC: 8104131.
DOI: 10.1158/1055-9965.EPI-20-1193.
Analysis of Italian Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy.
Figlioli G, De Nicolo A, Catucci I, Manoukian S, Peissel B, Azzollini J
Cancers (Basel). 2021; 13(3).
PMID: 33573335
PMC: 7866799.
DOI: 10.3390/cancers13030532.